Phase II study of Troxatyl ™ in patients with chronic myeloid leukemia in blastic phase (CML-BP).

被引：0
|
作者：
Giles, F
Feldman, E
Cortes, J
Faderl, S
Larson, R
Mamus, S
Thomas, D
Garcia-Manero, G
O'Brien, S
Beran, M
Talpaz, M
Kantarjian, H
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Cornell Univ, New York, NY USA
[3] Univ Chicago, Canc Res Ctr, Chicago, IL USA
[4] Univ Texas, MD Anderson Canc Ctr, Orlando, FL USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4764
引用
收藏
页码：258B / 258B
页数：1
相关论文
共 50 条
  • [41] Management of Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia in the Accelerated or Blastic Phase
    Deotare, Uday
    Kim, Dennis Dong Hwan
    Lipton, Jeffrey H.
    DRUGS & AGING, 2016, 33 (05) : 335 - 345
  • [42] Management of Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia in the Accelerated or Blastic Phase
    Uday Deotare
    Dennis Dong Hwan Kim
    Jeffrey H. Lipton
    Drugs & Aging, 2016, 33 : 335 - 345
  • [43] CHEMOTHERAPY FOR PATIENTS IN THE BLASTIC PHASE OF PH-POSITIVE CHRONIC MYELOID-LEUKEMIA
    SADAMORI, N
    ACTA HAEMATOLOGICA JAPONICA, 1990, 53 (08): : 1594 - 1601
  • [44] Decitabine, a hypomethylating agent, is active for the treatment of chronic myelogenous leukemia (CML) in non-lymphoid blastic phase (BP).
    Sacchi, S
    Talpaz, M
    O'Brien, S
    Cortes, J
    Kantarjian, H
    BLOOD, 1998, 92 (10) : 252A - 252A
  • [45] Imatinib (Glivec®) in patients with Ph plus chronic myeloid leukemia in chronic phase after interferon failure:: Results of a phase II trial of the Italian Cooperative Study Group on CML (ICSG on CML).
    Bassi, S
    Trabacchi, E
    Bonifazi, F
    Testoni, N
    Luatti, S
    Alberti, D
    De Vivo, A
    Pane, F
    Martinelli, G
    Amabile, M
    Saglio, G
    Cilloni, D
    Montefusco, E
    Tura, S
    Rosti, G
    Baccarani, M
    BLOOD, 2002, 100 (11) : 783A - 783A
  • [46] QUALITY OF LIFE (QOL) IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML) ON IMATINIB. A PILOT STUDY
    Kalvodova, L.
    Doubek, M.
    Zackova, D.
    Dusek, L.
    Jurova, M.
    Mayer, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 499 - 499
  • [47] ABERRATIONS OF CHROMOSOME NO 1 IN BLASTIC PHASE OF CHRONIC MYELOID-LEUKEMIA
    ALIMENA, G
    DALLAPICCOLA, B
    MITELMAN, F
    MONTUORO, A
    HEREDITAS, 1980, 92 (01) : 59 - 63
  • [48] CHROMOSOMAL-ABNORMALITIES OF THE BLASTIC PHASE OF CHRONIC MYELOID-LEUKEMIA
    STOLL, C
    PATHOLOGIE BIOLOGIE, 1982, 30 (09): : 755 - 758
  • [49] CHRONIC MYELOID LEUKEMIA TREATMENT IN BLASTIC PHASE WITH IMATINIB 600 MG
    Ionita, H.
    Ionita, I.
    Pacurar, R.
    Cheveresan, L.
    Ionita, C. O.
    Cheveresan, M.
    Nicola, D. E.
    Ionita, M.
    Oros, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 544 - 544
  • [50] Cladribine combined with mitoxantrone in the treatment of blastic phase of chronic myeloid leukemia
    Robak, T
    Góra-Tybor, J
    NEOPLASMA, 2001, 48 (03) : 203 - 207
12345